Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Financière de Tubize

Financière de Tubize
PUBLIC STATUS
201-300 EMPLOYEES
TUB STOCK SYMBOL
$69.69 SHARE PRICE (As of Thursday Closing)
Description

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a global biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Most of its sales revenue is derived from its neurology products, followed by its immunology products. The company's strategy focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Asset Management
Other Industries
Holding Companies
Stock Exchange
BRU
Primary Office
  • Allee de la Recherche 60
  • 1070 Anderlecht
  • Belgium

+32 0476 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Financière de Tubize’s full profile, request a free trial.

Financière de Tubize Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$60.39 - $77.67 $3.1B $68.77 $6.02 6.38K 44.5M

Financière de Tubize Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,885,076
Revenue 0
EBITDA 267,840 339,299 305,360 205,418
Net Income 267,840 336,503 322,466 200,418
Total Assets 2,901,522 2,840,999 2,772,907 2,337,742
Total Debt 97,862 163,135 230,516 253,457
Public Fundamental Data provided by Morningstar, Inc. disclaimer